Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00856427 · ClinicalTrials.gov registry record · Phase 1
Implantation of Markers for the Radiotherapy of Lung Cancer Patients
A Phase 1 study, sponsored by Virginia Commonwealth University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT00856427 is a Phase 1 study that was terminated before completion, run by Virginia Commonwealth University. The registered enrollment target is 6 participants.
The verdict
NCT00856427, a Phase 1 study, was terminated before completion, sponsored by Virginia Commonwealth University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
This clinical trial studies imaging markers in planning radiation therapy in patients with lung cancer. Implanting markers in the tumor that can be seen using imaging procedures during radiation therapy may allow x-rays to be sent directly to the tumor and cause less damage to normal tissue.
Interventions
- RADIATION radiation therapy treatment planning/simulation
- PROCEDURE implanted fiducial-based imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2008-02 |
| Est. Completion | 2012-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00856427
The ClinicalTrials.gov registry entry for NCT00856427 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which radiation therapy treatment planning/simulation is the first listed.
NCT00856427 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00856427 about?
NCT00856427 is a clinical study titled "Implantation of Markers for the Radiotherapy of Lung Cancer Patients". This clinical trial studies imaging markers in planning radiation therapy in patients with lung cancer. Implanting markers in the tumor that can be seen using imaging procedures during radiation therapy may allow x-rays to be sent directly to the tumor and cause less damage to normal tissue.
What is the current status of trial NCT00856427?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2008-02. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00856427?
The interventions under investigation include: radiation therapy treatment planning/simulation (RADIATION), implanted fiducial-based imaging (PROCEDURE).
Who is sponsoring clinical trial NCT00856427?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.